My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 103

    1.

    Correction: cost-effectiveness of statins in older patients with myocardial infarction.

    Ganz DA, Kuntz KM, Benner JS, Avorn J.

    Ann Intern Med. 2002 Apr 16;136(8):635. No abstract available. PMID: 11955042 [PubMed - indexed for MEDLINE]Related articles

    2.

    Cost of cerivastatin in cost-effectiveness study.

    Chung KC, Pomerantz K, Harrison B.

    Am J Health Syst Pharm. 2000 Sep 15;57(18):1712-3. No abstract available. PMID: 11006802 [PubMed - indexed for MEDLINE]Related articles

    3.

    Cost effectiveness of statins for the secondary prevention of coronary heart disease in Ireland.

    Barry M, Heerey A.

    Ir Med J. 2002 May;95(5):133-5. No abstract available. PMID: 12092692 [PubMed - indexed for MEDLINE]Related articles

    4.

    Incremental benefit and cost-effectiveness of high-dose statin therapy in high-risk patients with coronary artery disease.

    Chan PS, Nallamothu BK, Gurm HS, Hayward RA, Vijan S.

    Circulation. 2007 May 8;115(18):2398-409. Epub 2007 Apr 23.PMID: 17452609 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    A systematic review and economic evaluation of statins for the prevention of coronary events.

    Ward S, Lloyd Jones M, Pandor A, Holmes M, Ara R, Ryan A, Yeo W, Payne N.

    Health Technol Assess. 2007 Apr;11(14):1-160, iii-iv. Review.PMID: 17408535 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Summaries for patients. The cost-effectiveness of aspirin, statins, or both drugs in the primary prevention of heart disease.

    [No authors listed]

    Ann Intern Med. 2006 Mar 7;144(5):I29. No abstract available. PMID: 16520469 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Hydroxymethylglutaryl-CoA reductase inhibitors in older persons with acute myocardial infarction: evidence for an age-statin interaction.

    Foody JM, Rathore SS, Galusha D, Masoudi FA, Havranek EP, Radford MJ, Krumholz HM.

    J Am Geriatr Soc. 2006 Mar;54(3):421-30.PMID: 16551308 [PubMed - indexed for MEDLINE]Related articles

    8.

    Cost-effectiveness of statins in the prevention of coronary heart disease events in middle-aged Finnish men.

    Peura P, Martikainen J, Soini E, Hallinen T, Niskanen L.

    Curr Med Res Opin. 2008 Jun;24(6):1823-32. Epub 2008 May 15.PMID: 18485270 [PubMed - indexed for MEDLINE]Related articles

    9.

    Economic analysis of treatments reducing coronary heart disease mortality in England and Wales, 2000-2010.

    Fidan D, Unal B, Critchley J, Capewell S.

    QJM. 2007 May;100(5):277-89. Epub 2007 Apr 21.PMID: 17449875 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Cost effectiveness of statins in coronary heart disease.

    Franco OH, Peeters A, Looman CW, Bonneux L.

    J Epidemiol Community Health. 2005 Nov;59(11):927-33. Review.PMID: 16234419 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Cholesterol-lowering therapy with pravastatin in patients with average cholesterol levels and established ischaemic heart disease: is it cost-effective?

    Glasziou PP, Eckermann SD, Mulray SE, Simes RJ, Martin AJ, Kirby AC, Hall JP, Caleo S, White HD, Tonkin AM.

    Med J Aust. 2002 Oct 21;177(8):428-34.PMID: 12381252 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Lifetime cost effectiveness of simvastatin in a range of risk groups and age groups derived from a randomised trial of 20,536 people.

    Heart Protection Study Collaborative, Mihaylova B, Briggs A, Armitage J, Parish S, Gray A, Collins R.

    BMJ. 2006 Dec 2;333(7579):1145. Epub 2006 Nov 10.PMID: 17098764 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    A cost-effectiveness analysis of fluvastatin in patients with diabetes after successful percutaneous coronary intervention.

    Scuffham PA, Chaplin S.

    Clin Ther. 2005 Sep;27(9):1467-77.PMID: 16291420 [PubMed - indexed for MEDLINE]Related articles

    14.

    The cost-effectiveness of fluvastatin in Hungary following successful percutaneous coronary intervention.

    Scuffham PA, Kósa J.

    Cardiovasc Drugs Ther. 2006 Aug;20(4):309-17.PMID: 16779529 [PubMed - indexed for MEDLINE]Related articles

    15.

    An economic evaluation of fluvastatin used for the prevention of cardiac events following successful first percutaneous coronary intervention in the UK.

    Scuffham PA, Chaplin S.

    Pharmacoeconomics. 2004;22(8):525-35.PMID: 15217308 [PubMed - indexed for MEDLINE]Related articles

    16.

    Are the benefits of statins a class effect?

    Wright JM.

    CMAJ. 2005 Apr 26;172(9):1195-6. No abstract available. PMID: 15851713 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Statins for everyone--(even for those at low risk.) Experts are excited, but the question is whether benefits would outweigh costs.

    [No authors listed]

    Duke Med Health News. 2009 Feb;15(2):1, 11. No abstract available. PMID: 19358321 [PubMed - indexed for MEDLINE]Related articles

    18.

    Drug insight: Statin use in the elderly.

    Raffel OC, White HD.

    Nat Clin Pract Cardiovasc Med. 2006 Jun;3(6):318-28. Review.PMID: 16729010 [PubMed - indexed for MEDLINE]Related articles

    19.

    Implementing guidelines in primary care: can population impact measures help?

    Heller RF, Edwards R, McElduff P.

    BMC Public Health. 2003 Jan 23;3:7. Epub 2003 Jan 23.PMID: 12542840 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Cost-effectiveness analyses.

    Clark CM.

    Ann Intern Med. 2001 Sep 4;135(5):382-3. No abstract available. PMID: 11529708 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity